Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...

A nasal spray can tamp down potentially fatal reactions, a boon to the many patients in crisis who fear using EpiPens. Neffy, a new device approved by the Food and Drug Administration, is the ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.

The Food and Drug Administration approved a new nasal spray Friday as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray, which is made by ARS ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological research.

Scientists at Harvard Medical School have developed a simple nasal spray, made of harmless ingredients, that they reckon can protect us against flu, colds and COVID-19 with near-100% success.

The makers of a nasal spray launched last year by start-up Akita Biosciences have pulled back the curtain on how their product works (Adv. Mater. 2024, DOI: 10.1002/adma.202406348). The company ...

The nasal spray "Neffy" is the first needle-free option for severe allergic reactions that the FDA has approved. The spray would be an alternative to EpiPens.

Neffy, a single-dose nasal spray administered into one nostril, is approved for use in adult and pediatric patients who weigh at least 30 kilograms.

The progression of the disease could be delayed by several years using a new nasal spray treatment.

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against various respiratory infections, including COVID-19, influenza ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at least 66 pounds. It should be available in the next few months.